سعر هيبيريكس لقاح فيال وسرنجة معبأة مسبقا 2025

Hiberix, Haemophilus influenzae type b (Hib) conjugate vaccine (tetanus toxoid conjugate) for intramuscular injection, by GlaxoSmithKline (distributed in Egypt by Modern Pharma).

• Active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b in children aged 6 weeks through 4 years (before the fifth birthday).Population: Children 6 weeks through 4 yearsDailyMed (U.S. National Library of Medicine)

• Common solicited reactions (20% or more): injection-site pain and redness, irritability, drowsiness, fever, loss of appetite, fussiness and restlessness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Severe allergic reaction (e.g. anaphylaxis) after a previous dose of any H. influenzae type b- or tetanus toxoid-containing vaccine or to any component of the vaccine.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• If Guillain-Barré syndrome occurred within 6 weeks of a prior tetanus toxoid-containing vaccine, base the decision to vaccinate on potential benefits and risks.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Syncope can occur with injectable vaccines; procedures should be in place to avoid falling injury.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Apnoea after intramuscular vaccination has been observed in some prematurely born infants; base timing on the infant's medical status.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid: Induces antibodies against the Hib capsular polysaccharide (PRP); conjugation to tetanus toxoid makes the response T-cell dependent so that it works in infants.